102 related articles for article (PubMed ID: 25531052)
1. The role of CT10 regulation of kinase-like in cancer.
Guo C; Liu S; Sun MZ
Future Oncol; 2014 Dec; 10(16):2687-97. PubMed ID: 25531052
[TBL] [Abstract][Full Text] [Related]
2. CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.
Wang J; Chen X; Li P; Su L; Yu B; Cai Q; Li J; Yu Y; Liu B; Zhu Z
Chem Biol Interact; 2013 Nov; 206(2):230-8. PubMed ID: 24055140
[TBL] [Abstract][Full Text] [Related]
3. CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion.
Yanagi H; Wang L; Nishihara H; Kimura T; Tanino M; Yanagi T; Fukuda S; Tanaka S
Biochem Biophys Res Commun; 2012 Feb; 418(1):104-9. PubMed ID: 22244889
[TBL] [Abstract][Full Text] [Related]
4. The Tumor Suppressor SASH1 Interacts With the Signal Adaptor CRKL to Inhibit Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.
Franke FC; Müller J; Abal M; Medina ED; Nitsche U; Weidmann H; Chardonnet S; Ninio E; Janssen KP
Cell Mol Gastroenterol Hepatol; 2019; 7(1):33-53. PubMed ID: 30480076
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-379 Suppresses Cervical Cancer Cell Proliferation and Invasion by Directly Targeting V-crk Avian Sarcoma Virus CT10 Oncogene Homolog-Like (CRKL).
Shi X; Xiao X; Yuan N; Zhang S; Yuan F; Wang X
Oncol Res; 2018 Aug; 26(7):987-996. PubMed ID: 29295725
[TBL] [Abstract][Full Text] [Related]
6. Crk and CrkL are required for cell transformation by v-fos and v-ras.
Koptyra M; Park TJ; Curran T
Mol Carcinog; 2016 Jan; 55(1):97-104. PubMed ID: 25557916
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).
Park T; Koptyra M; Curran T
J Biol Chem; 2016 Dec; 291(51):26273-26290. PubMed ID: 27807028
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
9. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.
Pham TH; Gao X; Singh G; Hardwidge PR
J Biol Chem; 2013 Nov; 288(48):34567-74. PubMed ID: 24145029
[TBL] [Abstract][Full Text] [Related]
11. Crk at the quarter century mark: perspectives in signaling and cancer.
Kumar S; Fajardo JE; Birge RB; Sriram G
J Cell Biochem; 2014 May; 115(5):819-25. PubMed ID: 24356912
[TBL] [Abstract][Full Text] [Related]
12. CRKL overexpression suppresses in vitro proliferation, invasion and migration of murine hepatocarcinoma Hca-P cells.
Lin Q; Sun MZ; Guo C; Shi J; Chen X; Liu S
Biomed Pharmacother; 2015 Feb; 69():11-7. PubMed ID: 25661331
[TBL] [Abstract][Full Text] [Related]
13. Active (p)CrkL is overexpressed in human malignancies: potential role as a surrogate parameter for therapeutic tyrosine kinase inhibition.
Singer CF; Hudelist G; Lamm W; Mueller R; Handl C; Kubista E; Czerwenka K
Oncol Rep; 2006 Feb; 15(2):353-9. PubMed ID: 16391854
[TBL] [Abstract][Full Text] [Related]
14. CRKL oncogene is downregulated by p53 through miR-200s.
Tamura M; Sasaki Y; Kobashi K; Takeda K; Nakagaki T; Idogawa M; Tokino T
Cancer Sci; 2015 Aug; 106(8):1033-40. PubMed ID: 26079153
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of glioblastoma phenotypes in vitro establishes cell migration as a robust readout of Crk and CrkL activity.
Park T; Large N; Curran T
J Biol Chem; 2021; 296():100390. PubMed ID: 33561443
[TBL] [Abstract][Full Text] [Related]
16. CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation.
Suda K; Mizuuchi H; Murakami I; Uramoto H; Tanaka F; Sato K; Takemoto T; Iwasaki T; Sekido Y; Yatabe Y; Mitsudomi T
Lung Cancer; 2014 Aug; 85(2):147-51. PubMed ID: 24939008
[TBL] [Abstract][Full Text] [Related]
17. Essential roles of Crk and CrkL in fibroblast structure and motility.
Park TJ; Curran T
Oncogene; 2014 Oct; 33(43):5121-32. PubMed ID: 24166500
[TBL] [Abstract][Full Text] [Related]
18. Potential role of annexin A7 in cancers.
Guo C; Liu S; Greenaway F; Sun MZ
Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.
Yeung CL; Ngo VN; Grohar PJ; Arnaldez FI; Asante A; Wan X; Khan J; Hewitt SM; Khanna C; Staudt LM; Helman LJ
Oncogene; 2013 Nov; 32(47):5429-38. PubMed ID: 23318429
[TBL] [Abstract][Full Text] [Related]
20. Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma.
Wang J; Che YL; Li G; Liu B; Shen TM; Wang H; Linghu H
Mol Carcinog; 2011 Jul; 50(7):506-15. PubMed ID: 21319228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
